Wolfgang Jungraithmayr | Medicine and Dentistry | Lifetime Achievement Award

Posted on by Phenomenological Research

Lifetime Achievement Award

Wolfgang Jungraithmayr
University Hospital of Rostock, Germany

Wolfgang Jungraithmayr
Researcher Wolfgang Jungraithmayr
Affiliation University Hospital of Rostock
Country Germany
Scopus ID 25621008100
Documents 129
Citations 2,929
h-index 28
Subject Area Medicine and Dentistry
Event International Phenomenological Research Awards
ORCID 0000-0002-1442-4862

Wolfgang Jungraithmayr, MD, PhD, is a German thoracic surgeon, clinician-scientist, educator, and academic leader serving as Chair and Full Professor of Thoracic Surgery at the University Hospital of Rostock. His research portfolio spans lung transplantation, thoracic oncology, immunology, translational medicine, and experimental surgery. He is particularly recognized for pioneering the orthotopic mouse lung transplantation model and for advancing translational research into lung cancer immunotherapy and transplant immunology.[1]

Abstract

This article evaluates the scholarly achievements, research leadership, educational contributions, and international influence of Wolfgang Jungraithmayr in the fields of thoracic surgery, lung transplantation, and translational oncology. His work integrates clinical practice with experimental science, contributing to advances in transplant immunology, lung cancer therapeutics, and surgical innovation. Through sustained research productivity, competitive grant acquisition, international collaboration, and extensive scientific mentorship, he has established a distinguished academic profile suitable for consideration for lifetime recognition within the biomedical sciences.[1]

Keywords

Thoracic Surgery; Lung Transplantation; Lung Cancer; Immunology; Translational Medicine; CD26; Experimental Surgery; Academic Leadership; Oncology; Lifetime Achievement.

Introduction

Wolfgang Jungraithmayr has developed an interdisciplinary academic career combining thoracic surgical practice, translational biomedical research, and university-level education. Following medical training in Germany and advanced specialization in Switzerland, he completed doctoral research in immunology at the University and ETH Zurich. His subsequent appointments included leadership positions at the University Hospital Zurich, Medical University Brandenburg, and University Hospital Rostock, where he currently serves as Chair of Thoracic Surgery.[2]

His scientific activities have focused on improving outcomes in lung transplantation, understanding immune-mediated disease mechanisms, and identifying novel therapeutic targets for thoracic malignancies. These efforts have produced a substantial body of peer-reviewed literature and attracted significant competitive funding from European research agencies.[1]

Research Profile

Wolfgang Jungraithmayr’s research program centers on lung transplantation biology, transplant tolerance, tumour immunology, and translational thoracic oncology. A major contribution of his laboratory has been the establishment and dissemination of the orthotopic mouse lung transplantation model, which has become a valuable experimental platform for investigating immune responses, rejection mechanisms, and therapeutic interventions across multiple disciplines.[3]

His laboratory has secured more than €3.2 million in competitive research funding, including support from the German Research Foundation (DFG), Swiss National Science Foundation (SNSF), and other major funding bodies. Research projects have addressed chronic lung allograft dysfunction, immune regulation, magnetic resonance imaging applications, angiogenesis, and targeted immunotherapeutic approaches against lung adenocarcinoma.[1]

Research Contributions

Wolfgang Jungraithmayr’s principal research contributions include pioneering murine lung transplantation models, advancing transplant immunology, investigating immune tolerance mechanisms, identifying novel therapeutic targets in lung cancer, and improving understanding of ischemia-reperfusion injury and chronic allograft dysfunction.[2][4][5][6]

Publications

Recent publications highlight Jungraithmayr’s contributions to transplantation immunology, lung transplant outcomes, ischemia-reperfusion injury, and experimental models of chronic allograft dysfunction, demonstrating sustained impact in thoracic surgery and translational research.[2][3][4][5][6]

Wolfgang Jungraithmayr has authored more than 160 scientific publications and maintains a sustained record of peer-reviewed research. Representative publications reflect his contributions to lung transplantation, transplant immunology, and thoracic oncology.[1]

Research Impact

According to Scopus metrics, Jungraithmayr has accumulated 129 indexed documents, 2,929 citations, and an h-index of 28. These indicators demonstrate sustained scholarly influence within thoracic surgery, transplantation science, and oncology research.[1]

Beyond publication metrics, his impact is reflected through international teaching initiatives, reviewer responsibilities for leading journals, grant-review service for major funding agencies, editorial board memberships, and mentorship of emerging clinicians and scientists. His laboratory has trained investigators from numerous institutions across Europe, North America, and Asia, thereby extending the global reach of his methodological innovations.[1]

Award Suitability

Several factors support consideration of Wolfgang Jungraithmayr for a Lifetime Achievement Award. These include his longstanding record of scientific productivity, leadership of internationally recognized research programs, establishment of innovative experimental models, successful acquisition of competitive funding, extensive educational activities, and receipt of numerous international scientific distinctions. His contributions have influenced both clinical practice and experimental biomedical research, particularly in thoracic surgery and transplantation science.[1]

The cumulative scope of his achievements illustrates a sustained commitment to advancing medical knowledge, supporting scientific collaboration, and fostering the development of future generations of clinician-scientists.[2]

Conclusion

Wolfgang Jungraithmayr represents a notable figure in contemporary thoracic surgery and translational medicine. Through pioneering research, academic leadership, international educational engagement, and sustained scientific productivity, he has contributed significantly to the advancement of lung transplantation and thoracic oncology. His record of achievement, influence, and service provides a strong basis for recognition within the framework of a Lifetime Achievement Award.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Wolfgang Jungraithmayr, Author ID 25621008100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=25621008100
  2. Ohm B, Giannou AD, Harriman DI, Jungraithmayr WM, Zazara DE, et al. (2025). Chimerism and Immunological Tolerance in Solid Organ Transplantation. Immunologic Research. https://link.springer.com/article/10.1007/s00281-025-01052-x
  3. Moneke I, Ogutur ED, Kornyeva A, Jungraithmayr WM, Frye BC, et al. (2024). Donor Age Over 55 Is Associated With Worse Outcome in Lung Transplant Recipients With Idiopathic Pulmonary Fibrosis. BMC Pulmonary Medicine, 2024. https://link.springer.com/article/10.1186/s12890-024-03317-x
  4. Sander ML, Eulenburg V, Maeyashiki T, Jungraithmayr WM, Piegeler T, et al. (2024). Remote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model. Transplantation Proceedings, 2024. DOI: https://doi.org/10.1016/j.transproceed.2024.10.020
  5. Coppens A, Verleden SE, Claes E, Voet H, Verleden GM, Lapperre TS, Yildirim AÖ, et al. (2024). Murine Orthotopic Lung Transplant Models: A Comprehensive Overview of Genetic Mismatch Degrees and Histopathological Insights Into Chronic Lung Allograft Dysfunction. American Journal of Transplantation, 2024. DOI: https://doi.org/10.1016/j.ajt.2024.07.033
  6. Jungraithmayr W. (2020). Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury. Frontiers in Physiology, 2020. DOI: https://doi.org/10.3389/fphys.2020.581420

Iker Alonso González | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research

Mr. Iker Alonso González | Medicine and Dentistry | Best Researcher Award 

FACULTATIVO ESPECIALISTA MEDICO-TECNICO EN MICROBIOLOGÍA Y PARASITOLOGÍA at Cruces University Hospital | Spain

Mr. Iker Alonso González is a dedicated researcher and professional in the field of microbiology and clinical parasitology, recognized for his growing contributions to medical and pharmaceutical sciences. He holds a degree in Pharmacy from the University of the Basque Country (UPV/EHU) and has further specialized in Microbiology and Clinical Parasitology at Cruces University Hospital, where he continues to advance his expertise in infectious disease research and diagnostics. His professional experience at Osakidetza the Basque Health Service combines clinical practice with applied research, focusing on microbial resistance, infectious disease control, and antibiotic stewardship. He has presented numerous research communications, including fourteen posters and two oral presentations at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), addressing critical topics such as antimicrobial resistance patterns in Shigella spp. and the clinical impact of post-treatment uroculture interventions. His scientific publication, “Multiresistant Aeromonas hydrophila bacteremia,” published in Enferm Infecc Microbiol Clin (Engl Ed), reflects his analytical approach and contribution to understanding emerging multidrug-resistant pathogens. His current research interests center around the development of evidence-based antimicrobial protocols, optimization of laboratory diagnostics, and epidemiological monitoring of infectious diseases in clinical settings. Mr. Iker Alonso González’s participation in national research forums and professional societies highlights his commitment to academic collaboration and scientific advancement. His early scholarly impact is reflected in his record of 2 citations by 2 documents, 3 published works, and an h-index of 1, indicating a promising trajectory in medical research. He is also engaged in continuous professional development, ensuring alignment with global standards in clinical microbiology and pharmaceutical practice. Through his rigorous research, clinical application, and scholarly engagement, Mr. Iker Alonso González exemplifies the integration of scientific inquiry and healthcare innovation, contributing to the ongoing efforts to enhance antimicrobial stewardship and patient outcomes in contemporary medicine.

Profile: Scopus

Featured Publications:

  • Alonso-González, I. (2025). Upper limb abscess due to an unusual Clostridium species in an immunocompetent child. Enfermedades Infecciosas y Microbiología Clínica.

  • Alonso-González, I. (2023). Sensitivity profile of Shigella spp. isolates in patients with travelers’ diarrhea in a tertiary hospital in the period 2017–2022. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2023). Impact of a PROA intervention on the request of non-proven post-treatment control urocultures. Presented at the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC).

  • Alonso-González, I. (2022). Multiresistant Aeromonas hydrophila bacteremia. Enfermedades Infecciosas y Microbiología Clínica

 

Barbara Ariue | Medicine and Dentistry | Best Researcher Award

Posted on by Phenomenological Research

Dr. Barbara Ariue | Medicine and Dentistry | Best Researcher Award 

Dr. Barbara Ariue is a distinguished medical professional and academic leader specializing in pediatric allergy and immunology, recognized for her outstanding contributions to research, education, and clinical innovation. As an Associate Professor of Pediatrics at a leading medical institution, she has dedicated her career to advancing the understanding and management of pediatric asthma, allergic conditions, stinging insect allergies, and immunodeficiency disorders. Her academic journey reflects a deep commitment to excellence in both teaching and scientific inquiry, inspiring medical students and resident physicians to pursue evidence-based and compassionate patient care. Dr. Barbara Ariue’s research has significantly impacted the field, particularly through her pioneering project, “Addressing Knowledge Gaps in Diagnosing and Managing Inborn Errors of Immunity,” which received a planning grant from the Allergists’ Foundation Community Grant Program under the American College of Allergy, Asthma, and Immunology. The project evaluates diagnostic practices, interdisciplinary collaboration, and educational needs in managing immunodeficiencies, leading to her recent publication, “Lessons from the ACAAI Survey: Advancing the Diagnostic and Therapeutic Strategies for the Practicing Allergist-Immunologist,” in the Annals of Allergy, Asthma, and Immunology. Her scholarly output includes publications in prestigious journals such as Journal of Clinical Immunology, Pediatrics, and Biochemical and Biophysical Research Communications. In addition to her research, she serves as a consultant and advisory board member for various pharmaceutical organizations, contributing her expertise to clinical trials and therapeutic advancements in immunology. Professionally, she holds fellowships and leadership positions in numerous medical societies, including the American College of Allergy, Asthma, and Immunology, and the American Academy of Pediatrics, reflecting her influence in shaping professional standards in allergy and immunology. Her citation index demonstrates 168 citations by 168 documents, with 11 publications and an h-index of 6, underscoring the impact and reach of her scientific work. Dr. Barbara Ariue’s career embodies a balance of clinical dedication, academic leadership, and research excellence, with her contributions continually shaping the future of pediatric immunology and fostering global advancements in medical science and patient care.

Profile: Scopus | Orcid  

Featured Publications:

  • Oh, C. K., Ariue, B., Alban, R. F., Shaw, B., & Cho, S. H. (2002). PAI-1 promotes extracellular matrix deposition in the airways of a murine asthma model. Biochemical and Biophysical Research Communications, 294(5), 1155–1160.

  • Heimall, J., Keller, M., Saltzman, R., Bunin, N., McDonald-McGinn, D., Ariue, B., … Markert, M. L. (2012). Diagnosis of 22q11.2 deletion syndrome and Artemis deficiency in two children with T-B-NK+ immunodeficiency. Journal of Clinical Immunology, 32(5), 1141–1144.

  • Cho, S. H., Hall, I. P., Wheatley, A., Ariue, B. K., Abraha, D., Delmundo, J., & Oh, C. K. (2001). The possible role of plasminogen activator inhibitor-1 gene in the development of asthma. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K., Cho, S. H., Tam, S. W., & Oh, C. K. (2001). 142 Analysis of airway remodeling genes in human mast cells by cDNA microarrays. Journal of Allergy and Clinical Immunology, 107.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 43 – Anaphylaxis (in book chapter). In Pediatrics. Mosby Inc.

  • Ariue, B. K. & Oh, C. K. (2005). Chapter 48 – Insect allergies (in book chapter). In Pediatrics. Mosby Inc.

  • McDonnell, J., Angarola, B., Ariue, B., Arnold, D. E., Assa’ad, A. H., Aytekin, C., … Bleesing, J. (2024). COVID-19 vaccination in patients with inborn errors of immunity reduces hospitalization and critical care needs: a USIDNET report. Journal of Clinical Immunology.